These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33009758)

  • 1. Stroke and the immune system: A review of the new strategies.
    Todorov V; Dimitrova M
    Folia Med (Plovdiv); 2020 Sep; 62(3):431-437. PubMed ID: 33009758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunology of stroke: from mechanisms to translation.
    Iadecola C; Anrather J
    Nat Med; 2011 Jul; 17(7):796-808. PubMed ID: 21738161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
    Shekhar S; Cunningham MW; Pabbidi MR; Wang S; Booz GW; Fan F
    Eur J Pharmacol; 2018 Aug; 833():531-544. PubMed ID: 29935175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune system in stroke: clinical challenges and their translation to experimental research.
    Smith CJ; Lawrence CB; Rodriguez-Grande B; Kovacs KJ; Pradillo JM; Denes A
    J Neuroimmune Pharmacol; 2013 Sep; 8(4):867-87. PubMed ID: 23673977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emerging Role of Triggering Receptor Expressed on Myeloid Cells 2 as a Target for Immunomodulation in Ischemic Stroke.
    Gervois P; Lambrichts I
    Front Immunol; 2019; 10():1668. PubMed ID: 31379859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation after ischemic stroke: potential mechanisms and implications for therapy.
    Santos Samary C; Pelosi P; Leme Silva P; Rieken Macedo Rocco P
    Crit Care; 2016 Dec; 20(1):391. PubMed ID: 27923376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune and inflammatory responses to stroke: good or bad?
    McCombe PA; Read SJ
    Int J Stroke; 2008 Nov; 3(4):254-65. PubMed ID: 18811742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune mechanisms of stroke.
    Magnus T; Wiendl H; Kleinschnitz C
    Curr Opin Neurol; 2012 Jun; 25(3):334-40. PubMed ID: 22547104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic immune activation shapes stroke outcome.
    Murray KN; Buggey HF; Denes A; Allan SM
    Mol Cell Neurosci; 2013 Mar; 53():14-25. PubMed ID: 23026562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections.
    Faura J; Bustamante A; Miró-Mur F; Montaner J
    J Neuroinflammation; 2021 Jun; 18(1):127. PubMed ID: 34092245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Communications Between Peripheral and the Brain-Resident Immune System in Neuronal Regeneration After Stroke.
    Liu F; Cheng X; Zhong S; Liu C; Jolkkonen J; Zhang X; Liang Y; Liu Z; Zhao C
    Front Immunol; 2020; 11():1931. PubMed ID: 33042113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic stroke alters immune cell niche and chemokine profile in mice independent of spontaneous bacterial infection.
    Farris BY; Monaghan KL; Zheng W; Amend CD; Hu H; Ammer AG; Coad JE; Ren X; Wan ECK
    Immun Inflamm Dis; 2019 Dec; 7(4):326-341. PubMed ID: 31691533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial MHC class II constructs as novel immunomodulatory therapy for stroke.
    Benedek G; Vandenbark AA; Alkayed NJ; Offner H
    Neurochem Int; 2017 Jul; 107():138-147. PubMed ID: 27773790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological consequences of ischemic stroke: immunosuppression and autoimmunity.
    Vogelgesang A; Dressel A
    J Neuroimmunol; 2011 Feb; 231(1-2):105-10. PubMed ID: 20970200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation by interleukin-33 is protective in stroke through modulation of inflammation.
    Korhonen P; Kanninen KM; Lehtonen Š; Lemarchant S; Puttonen KA; Oksanen M; Dhungana H; Loppi S; Pollari E; Wojciechowski S; Kidin I; García-Berrocoso T; Giralt D; Montaner J; Koistinaho J; Malm T
    Brain Behav Immun; 2015 Oct; 49():322-36. PubMed ID: 26111431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combating innate inflammation: a new paradigm for acute treatment of stroke?
    Stoll G; Kleinschnitz C; Nieswandt B
    Ann N Y Acad Sci; 2010 Oct; 1207():149-54. PubMed ID: 20955438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactive Cells After Cerebral Ischemia.
    Wang Y; Zhang JH; Sheng J; Shao A
    Front Immunol; 2019; 10():2781. PubMed ID: 31849964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive Immunity Regulation and Cerebral Ischemia.
    Qin X; Akter F; Qin L; Cheng J; Guo M; Yao S; Jian Z; Liu R; Wu S
    Front Immunol; 2020; 11():689. PubMed ID: 32477327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune responses and neuroimmune modulation in the pathogenesis of acute ischemic stroke and poststroke infections].
    Papp V; Molnár T; Bánáti M; Illés Z
    Ideggyogy Sz; 2010 Jul; 63(7-8):232-46. PubMed ID: 20812451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Involvement and Therapy Target of Immune Cells After Ischemic Stroke.
    Jian Z; Liu R; Zhu X; Smerin D; Zhong Y; Gu L; Fang W; Xiong X
    Front Immunol; 2019; 10():2167. PubMed ID: 31572378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.